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A B S T R A C T
Objectives: The aim of the study is to screen and evaluate the efﬁcacy of the screening tools in detecting
subjects with sub-threshold psychosis among asymptomatic individuals at genetic risk, as compared
with persons in the general public.
Methods: This was a two-stage study of the relatives of patients with schizophrenia and general
individuals. Subjects were screened with a Screening Questionnaire (SQ) and General Health
Questionnaires (GHQ-12) in the initial stage. Those who screened positive were reassessed using the
Comprehensive Assessment of At-Risk Mental State (CAARMS) in the second stage.
Results: A total of 190 (29%) subjects initially screened positive from a sample of 660 individuals. The
proportion of persons in the general public (63%) who progressed to the second stage was signiﬁcantly
higher than at-risk relatives (37.4%) (X2 = 17.028, df = 1, p < 0.001). After ﬁnal assessment, about 4% of
the sample was positive; subjects at sub-threshold UHR (ultra-high risk) was higher (69%) than subjects
at UHR (31%). Detection rate was higher when both GHQ and SQ (26.4%) measures were positive in the
initial screening. In both categories of sub-threshold psychosis, the percentage of subjects at genetic risk
was higher (62%), and the proportion steadily increased as the psychosis progressed.
Conclusion: The prevalence of sub-threshold psychosis was higher in subjects at genetic risk. Clinical
assessment following a self-report questionnaire should be mandatory as the rate of false positive results
is high. The SQ has poor validation indexes, which is partly contributed to low detection rate and the GHQ
is not suitable for screening early psychosis.
 2015 Elsevier B.V. All rights reserved.
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It is believed that individuals who will develop schizophrenia go
through a variety of abnormal subjective experiences that progres-
sively develop during pre-puberty and puberty. Genetic high-risk
studies have indicated that subtle deﬁcits can be identiﬁed long
before psychosis emerges and these deﬁcits can serve as predictors
for later development of schizophrenia. Ideally, the prevention
should be conducted during these years to detect the disease before
symptoms are evident and progress to psychosis. The participants in
most of the studies were help-seeking adolescents who were already
affected by psychotic-like symptom. Such people cannot be targeted
with primary prevention because it is highly probable that an actual* Corresponding author. Tel.: +60 61267333; fax: +60 61265225.
E-mail addresses: razali6403@salam.uitm.edu.my, razali_s@rocketmai.coml
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1876-2018/ 2015 Elsevier B.V. All rights reserved.disease process has already begun (Cornblatt et al., 2002). The
intervention should be aimed at high risk individuals showing
minimal but detectable signs of possible incipient mental disorder,
and who do not meet the current diagnostic criteria.
There are a number of variables that confer some indication of
vulnerability to schizophrenia. Screening instruments have been
developed that incorporates vulnerable factors. However, there is
no single instrument capable of detecting individuals in the
prodromal phase with satisfying degrees of sensitivity and
speciﬁcity (Kline et al., 2012). Basic Symptoms (BSs) which is
presumably characterise the early prodromal phase, are closely
linked to hypothetical core vulnerability of schizophrenia. These
disturbances are presumed to be the phenotype of underlying
neurophysiological deﬁcits. The BSs are experiential, not beha-
vioural in kind and only recognisable by the self-report of the
patients. BSs are subjectively experienced disturbances of percep-
tion, cognition, language, motor function, will, initiative, level of
energy and stress tolerance (Gross, 1997), operationalized by the
Table 1
The Screening Questionnaires (SQ).
No. Psychphatology assessed
1 Perceptual disturbances (auditory)
2 Suspiciousness/Persecutory idea
3 Perceptual disturbances (visual)
4 Unusual thought content
5 Impaired ability to initiate social contact
6 Delusional ideas
7 Delusion of being controlled/thought interference
8 Clairvoyance/Sixth sense
9 Conceptual disorganisation
10 Distorted body experiences/impaired bodily sensation
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1987), or the shorter version, Schizophrenia Prediction Instru-
ment-Adult Version (SPI-A, Schultze-Lutter et al., 2004). The BSABS
operationalization of prodromal symptoms performed well in the
early detection of schizophrenia (Klosterkotter et al., 2001).
The ability to identify asymptomatic individuals at high risk
for psychosis through low cost screening is greatly beneﬁcial. The
screening instrument is used in the ﬁrst phase of a two-stage
study, which is followed by assessment either with the
Comprehensive Assessment of At-Risk Mental State (CAARMS,
Yung et al., 2002) or the Structured Interview for Prodromal
Symptoms (SIPS, McGlashen et al., 2003) in the second stage. The
CAARMS and SIPS as well as the other commonly used screening
instruments such as Prodromal Screening (PROD-Screen, Hei-
nima et al., 2003), Prodromal Questionnaires (PQ, Loewy et al.,
2005) and SIPS Screen (Miller et al., 2004) are based on the
attenuated positive syndrome (APS) approach, which is aimed to
detect the late prodromal phase, but less useful for detecting
early psychosis (Olsen and Rosenbaum, 2006). While the BSABS
(Gross et al., 1987) is more sensitive in detecting early prodromal
phase.
Screening instrument with good validation indexes should be
able to assess correctly asymptomatic individuals at risk (Corcoran
et al., 2005). The objective of the study is to detect subjects at sub-
threshold psychosis among the relatives of patients with
schizophrenia and people of the general public; and evaluate
the efﬁcacy of the screening tools. There is a growing consensus in
the ﬁeld that UHR and BSs approach are complementary, providing
criteria to detect different prodromal stages (Phillips et al., 2005).
In contrast, this study is exploring the utility of a single screening
instrument in detecting subjects at the earlier (sub-threshold UHR)
and late prodromal stage (UHR). We would use a previous local
screening questionnaire (Razali et al., 2011), which is design
mainly to cover APS psychopathology, and the General Health
Questionnaires (GHQ-12) in the initial stage. We hope to evaluate
the sensitivity of APS psychopathology and usefulness of GHQ-12
in screening early psychosis.
2. Methods
2.1. Subjects
The selected subjects were divided equally into two groups,
which were chosen through convenience sampling. The ﬁrst and
second degree relatives of patients with schizophrenia (DSM-IV-
TR, American Psychiatric Association, 2000) between 12 and 30
years formed the ﬁrst group; while the second group consisted of
individuals from the general population within the same age
group. The relatives of patients was selected for the study when
they visited psychiatric ward during visiting hours or when they
accompanied psychiatric patients to the psychiatric clinic of
Hospital USM. Other members of the family were then contacted
through telephone to arrange for an interview at home with the
assistance of the Community Mental Health Team (CMHT) if they
agreed for the study. Members of the general public were chosen
from among the patients’ neighbours, house-wives, hospital
visitors, pedestrians, civil servants, hospital administrative staff,
schools and college students. The Ethical Committee (Human),
Universiti Sains Malaysia (USM) reviewed the research protocol
and then approved the study.
2.1.1. Exclusion criteria
Subjects in both groups were excluded if they:
(i) declined to sign informed consent, or(ii) had past history of psychotic illness or being treated with
neuroleptics, or
(iii) had co-morbid substance abuse, mental retardation or organic
mental disorders
Individuals from the general population were excluded if they:
(i) had history of major psychotic illness among the ﬁrst and/or
second degree relatives.
2.2. Assessment
2.2.1. Initial screening
Research assistance (RA) started the preliminary (ﬁrst stage)
screening using a validated Malay version of Screening Question-
naire (SQ) (Table 1) and the General Health Questionnaires (GHQ-
12). The SQ is a 10-item question mainly covering APS
psychopathology, which was modiﬁed from the SIPS (McGlashen
et al., 2003). The cut-off scores of the SQ and GHQ-12 was 2 and 3
respectively (Razali et al., 2011).
2.2.2. Second stage screening
The research psychiatrists conducted the second stage assess-
ment using the Comprehensive Assessment of At-Risk Mental State
(CAARMS) and two other research tools, as summarized in the ﬂow
chart (Fig. 1). If positive ﬁndings were detected from CAARMS, they
were further explored to assess the severity, frequency and
duration of the symptoms. The Global Assessment of Function
(GAF) scale (DSM-IV-TR, American Psychiatric Association, 2000)
was then used to evaluate the current level of function. The
presence of schizotypal personality disorder (PD) in second degree
relatives and general individuals when their GAF scores dropped
more than 30% from premorbid level was assessed with The
Structured Clinical Interview for DSM-IV (SCID, American Psychi-
atric Association, 1994).
The positive subjects were classiﬁed according to two main
categories: UHR (early prodromal stage) and sub-threshold UHR
(late prodromal stage)
(i) The UHR category is further divided to two sub-groups (Yung
et al., 2004a):
(a) Brief limited intermittent psychotic symptoms (BLIPS) or
attenuated psychotic symptoms (APS).
(b) Vulnerable group (VG): The primary degree relatives and
other subjects with schizotypal PD who sustained at least
30% drop in GAF score from premorbid level for a month.
(ii) A sub-threshold UHR category consists of sub-threshold APS
(STAPS) and sub-threshold BLIPS (STBLIPS) in which the
positive symptom (severity scale score) is less severe or the
st
 deg ree relatives) 
nd
 degree  relati ves  an d pub lic) 
                                                                              VG  
Fig. 1. Flow chart of the screening.
Table 2
Number of cases who proceed to the second stage assessment and the outcome of
the assessment.
Proceed to the second stage
Proceed Genetic risk Public Total X2 (df) P
Yes 71 119 190
No 259 211 470
Total 330 330 660 17.028 (1) <0.001
Distribution of the positive subjects by genetic status
Outcome Genetic risk Public Total
Positive 18 11 29
Negative 53 108 161
Total 71 119 190
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of APS or BLIPS.
The operational criteria of sub-threshold UHR was deﬁned as
below (Yung et al., 2004a):
(a) Sub-threshold of APS (STAPS): Sub-threshold intensity: Severity
scale score of: 2 on disorder of thought content subscale, 2 on
perceptual abnormalities subscale, 3 on disorganised speech
subscales of the CAARMS, or a combination of these. Sub-
threshold frequency: Severity scale score of: 5 on the disorder of
thought content, 4 on perceptual abnormalities, 5 disorganised
speech subscales of the CAARMS, or a combination of these.
(b) Sub-threshold of BLIPS (STBLIPS). Severity scale score of 5 on
the disorder of thought content subscale, 4 on perceptual
abnormalities subscale, 5 on disorganised speech subscale of
the CAARMS, or a combination of these.
The subjects who scored higher than the psychotic threshold
according to CAARMS or developed full blown non-affective
psychosis (schizophrenia/schizophreniform disorder) were ex-
cluded from the study
2.3. Sample size and statistical analysis
We used single proportion formula to determine the sample
size. Based on the median prevalence rate of 5% of sub-clinical
psychosis in general population (Van Os et al., 2009) with 95%
conﬁdence interval and Z = 1.96, the calculated sample size is 73.
Data were analysed using SPSS for Windows, version 16.0 (Chicago,
IL., USA). Continuous data and categorical data were examined
using the Mann–Whitney U-test and the chi-Squared test
respectively. The statistical tests were two-tailed, with the level
of signiﬁcance set at p < 0.05.
3. Results
3.1. Initial screening
There were 330 subjects in each group. Majority (72.4%) of the
at-risk relatives were ﬁrst degree relatives and the mean age of this
group was 19.35  5.2 years; while the mean age of generalindividuals was 21.31  3.9 years. The subjects in both groups had
no signiﬁcant differences in age, gender and highest level of
education. A total of 190 (29%) subject initially screened positive
and they proceed to the second stage of study; of these, 71 (37%) were
at-risk relatives and 119 (63%) were individuals from the general
public.
3.2. Second stage screening
3.2.1. Distribution of cases
In the second stage of assessment, a total of 35 subjects which
comprised 22 at-risk relatives and 13 general individuals screened
positive. However, 6 subjects were excluded because they had
exceeded the psychotic threshold and were diagnosed with
schizophrenic form disorder/schizophrenia. Those with exceeded
psychotic score were four subjects at genetic risk and two general
individuals. The distribution of the 29 individuals with sub-
threshold psychosis by their genetic status is shown in Table 2.
There were 161 (85%) subjects with false positive, 108 were
general individuals and 53 genetic at-risk relatives.
3.2.2. Distribution of GHQ and SQ
Fifty three subjects had positive scores in both GHQ and SQ.
Altogether, 170 subjects were positive on SQ alone, 110 (33.3%)
general individuals and 60 (18.2%) at-risk relatives. The number of
general individuals with positive SQ score was signiﬁcantly higher
than at-risk relatives (X2 = 19.8079, df = 1, p < 0.001). Regarding the
GHQ score, of 73 subjects who scored positive, 40 (12.1%) were
general individuals. There were no signiﬁcant difference between
general individuals and at-risk relatives who scored positive on GHQ
(X2 = 0.7931, df = 1, p = 0.3732). The distribution of the GHQ and SQ
scores according to genetic status, was summarised in Table 3
3.2.3. Socio-demographic determinants of progressing to the second
stage
The number of general individuals (62.6%) who progressed to
the second stage was signiﬁcantly higher than at-risk relatives
(37.4%) (X2 = 17.028, df = 1, p < 0.001). Other socio-demographic
variables such as age, gender and highest level of education did not
inﬂuence the progression to the second stage (Table 4).
3.2.4. The detection rate of the screening tools
Among 190 positive subjects in the initial screening, a majority
117 (62%) was detected through SQ alone, while 53 (28%) were
detected by both GHQ and SQ; only 20 (10%) were detected by GHQ.
However, after the second stage screening, 29 cases of sub-threshold
psychosis were identiﬁed. The distribution of the cases were
summarised in Table 5. The SQ alone and the combination of the SQ
and GHQ detected the same number of cases (14 cases each), while
GHQ alone detected only 1 positive case. The combination of the
GHQ and SQ also detected all 6 psychotic cases which were excluded
Table 3
The distribution of GHQ and SQ scores of the general public and relatives at genetic
risk.
Scores GHQ SQ
Gen (%) Public (%) Gen (%) Public (%)
0 246 193 207 155
1 34 69 63 65
2 17 28 26 42
3 10 19 20 25
4 9 6 5 27
5 7 6 3 11
6 4 3 6 2
7 1 1 0 1
8 0 2 0 2
9 2 2 0 0
10 0 1 0 0
Total 330 330 330 330
Table 5
The detection rate of the screening tools and number of cases detected in the second
stage screening.
Positive and false positive cases following second stage screening
GHQ SQ GHQ + SQ Total
Positive 1 14 14 29
False positive 19 103 39 161
Total 20 117 53 190
Detection rate and diagnosis of the detected cases
Detection rate (%) 5 12 26.4
BLIPS/APS 0 4 5 9
STAPS/STBLIPS 1 10 9 20
Total 1 14 14 29
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GHQ were positive (26.4%), than when subjects screened positive
with SQ (12%) or GHQ alone (5%). Three genetic at-risk individuals
from second degree relatives had signiﬁcant drop in the GAF score
and proceed with schizotypal PD assessment; however, they did not
fulﬁl the criteria of Schizotypal P.D (SCID, 1994). Thus, VG was
excluded.
3.2.5. Final diagnosis and genetic status
Finally 29 (4%) subjects from the initial screening of 660 high
risk relatives and general population were positive. Among 29
individuals with sub-threshold psychosis (UHR and sub-threshold
UHR), a majority 18 (62%) were among the genetic at-risk relatives.
Regarding the distribution of positive subjects, 20 (69%) were
STAPS/STBLIPS (12 at genetic risk, 8 general individuals) and 9
(31%) were APS/BLIPS (6 at genetic risk, 3 general individuals).
None of the subjects with VG was detected. It was observed that
the genetic at-risk relatives’ proposition steadily increased as the
psychosis progressed; 67% UHR individuals were detected as
compared with 60% subjects with sub-threshold UHR.
4. Discussion
The study found that about 4% of the screened population was
positive for sub-threshold psychosis. Since they were not clinicallyTable 4
The relationship between subjects who proceed to the second stage with age,
gender, genetic status and educational background.
Variables Proceed N = 190 (%) X2 (df)/z p-value
Age
Mean (SD)
20.37 (4.4) 0.325 0.745*
Gender
Male
Female
136 (71.6)
54 (28.4)
2.897 (1) 0.089
Genetic
Public
Genetic risk
119 (62.6)
71 (37.4)
17.028 (1) <0.001
Education
Primary
Lower secondary
Upper secondary
College/Diploma
University
Professional
7 (3.7)
28 (14.7)
74 (38.9)
67 (35.3)
12 (17.4)
2 (2.8)
7.616 (5) 0.268
* Mann–Whitney Test.psychotic, sometimes they were categorised as having psychotic
Experiences (PEs) or Psychotic-like experience (PLE). The reported
prevalence of PEs found in this study is not much different from the
previous studies. DeVyider et al. (2014) found that 3.4% of the 10,
541 respondents in the general population reported PLE in the last
12 months; while the latest data from analysis of 31, 261
respondents in the WHO World Mental Health Survey of 18
counties (McGrath et al., 2015) revealed that 5.8% of them reported
at least one psychotic experience in their life time, with
hallucinatory experience being the most common (5.2%) as
compared with delusional experience (1.3%). The detection rate
in this study would be higher if the sampling method could be
improved; with convenience sampling those likely to be positive
cases may avoid from the study for fear of stigma or being labelled
as mentally ill. In Asian culture the stigma towards people with
severe mental illness (SMI) is strong; the public tends to boycott or
look down on them and their families (Ng, 1997).
A higher percentage of subjects (69%) at sub-threshold UHR
(STAPS/STBLIPS) were detected, as compared with subjects (31%)
at ultra-high risk (APS/BLIPS). Both categories are present in a
higher proportion (62%) among individuals at genetic-risk,
indicating that genetic factors play an important role in the
pathogenesis of major psychoses. Although individuals with PEs
are common in the general population, STAPS/STBLIPS and UHR are
two different categories. The status of UHR is more established and
has been widely studied. The people with UHR yielded a
conversion rate to full-blown psychosis of 30-50% (Yung et al.,
2003, 2004b), while the people with sub-threshold UHR most
likely had symptoms weakly associated with psychotic disorder
that will disappear over time (Van Os et al., 1999, 2009). It is
interesting to know why some people recover while others may
progress to full blown psychosis. Van Os et al. (2009) proposed
psychosis proneness-persistence-impairment model to predict the
future development of psychosis, which is based on environmental
exposure interacting with genetic risks. The other explanation is
the presence of BSs in the individuals’ subject. It was found that
about 50% of subjects with BSs in early prodromal phase
progressed to psychotic disorder within 9.6 years of follow up
(Klosterkotter et al., 2001).
Various screening instruments have been constructed with the
aim of recruiting individuals for further assessment. The success of
any screening program much depends on the validity and
reliability of the screening questionnaires. Loewy et al. (2012)
for instance found good predictive validity for later development of
psychosis in a two-stage screening processes, combining PQ and
SIPS; which is contributed by good validation index of the PQ. The
SQ and GHQ in this study seemed to have low sensitivity because a
high percentage of the subjects detected in the initial screening
were found to be false positive, and we speculate that its speciﬁcity
is better than the sensitivity. The low validation indexes of the SQ
are also contributed to low detection rate. This is consistence with
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and GHQ-12 had low sensitivity (Razali et al., 2011). The detection
rate of the SQ is 12%, which is higher than the GHQ (5%). When both
the SQ and GHQ were positive, the chance to detect a positive case is
much higher (26.4%). The GHQ-12 alone is not suitable for screening
early psychosis; thus it should be combined with other screening
instruments. The GHQ is rarely used in the study of early psychosis.
In our review we found that, Morrison et al. (2002) incorporated the
GHQ-28 (Goldberg and Hillier, 1979) with other instruments to
assess general at-risk mental state to deﬁne caseness.
The use of more than one instrument in the screening will help
clarifying the relation between symptoms targeted by the different
instruments (Olsen and Rosenbaum, 2006). Among the variables
measured in this study, the progress to the second stage of study
was only inﬂuenced by individuals’ genetic status. Surprisingly, a
signiﬁcantly higher number of general individuals progressed to
the second stage as compared with individuals with genetic risk. As
expected, the rate of false positive among them was high. There are
few reasons explaining for the discrepancy of the scoring. At-risk
subjects may underestimate their symptoms because of the
unrealistic nature of their experiences and belief. While general
individuals overestimate their symptoms or they could not
differentiate between psychotic symptoms and normal experi-
ences or interpreted them erroneously (Lincoln et al., 2010; Bell
et al., 2007). The other reason we had observed that some general
individuals purposely aggravated their symptoms in order to
continue with the second stage of the study.
We found that the rate of false positive was high (85%) in the
second stage assessment, which reﬂected the weakness of the SQ;
interestingly, a greater number of general individuals than the
relatives at risk proceeded to the second stage. This suggested that
general population screening for psychosis risk, using a self-report
questionnaire could result in a high false-positive rate. Thus, a
clinical assessment or re-interview following a self-report
questionnaire should be mandatory to eliminate false positive
individuals as implemented in this study. This is consistent with
the ﬁnding of the previous studies and suggestions by the others
(Hanssen et al., 2003; Kendler et al., 1996).
5. Limitation
The main limitation of this study is the weakness in the
sampling. The convenience sampling is considered as a weak
sampling method. This study needs universal sampling for proper
document of the prevalence. The SQ seems to have low sensitivity
which contributed to higher percentages of false positive cases in
the second stage. The speciﬁcity of the scale was also not satisﬁed.
This could be overcome by reassessment of selective negative cases
based on the initial screening, which had not been done in this
study. Other approach to improve the detection rate is applying
two different scales which is complementary to each other,
providing criteria to detect different prodromal stages separately;
late prodromal base scale (APS approach) and early prodromal base
scale (BSs approach). It is also important to follow up the positive
cases, especially among the at-risk family to assess their
progression to psychosis. However, this is beyond the scope of
this study.
6. Conclusion
A two-stage study is an effective and economical approach to
detect asymptomatic individuals with a known risk factor.
About 4% of the samples were positive for sub-threshold
psychosis and the prevalence was higher in subjects at genetic
risk. The success of screening programs much depends on the
sensitivity and speciﬁcity of the screening tools. Low detectionrate found in this study is partly related to poor validation
indexes of the SQ and the sampling weakness. Since it is almost
impossible to have a screening instrument with perfect
validation indexes, clinical examination or reassessment of
the positive cases and selective negative cases in the second
stage should be mandatory. For detection of subjects in
prodromal stage of psychosis, in order to improve detection
rate it is better to use two different scales which is
complementary to each other, providing criteria to detect
different prodromal stages, late and early prodromal.
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